Bayer confirms 2025 targets after solid start to the year

EBITDA before special items decreases to €4.08 billion (7.4%)

GPT Healthcare commissions new greenfield quaternary care hospital in Raipur

Lupin Diagnostics achieves NABL accreditation for all greenfield labs

The 27 greenfield labs across the country ensure timely and accurate reporting

Sigachi receives environmental clearance for greenfield Dahej manufacturing facility

The plant will have installed production capacity of 3,120 MT/month

Senores Pharmaceuticals begins operations at greenfield API facility

This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.

European Food Safety Authority confirms safety of silica as food additive

Silica is a proven and highly effective anti-caking agent that has been used for decades

Long-term efficacy and safety profile of Eylea 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years

Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years

Amcor's long-term SBTi targets confirmed

The net-zero target approval complements the company's near-term emission reduction targets

Presence of Mpox virus of West African clade 2 confirmed in isolated patient

This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards

Dupixent late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM

Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD